I. А. Vаsilyevа

2.6k total citations · 1 hit paper
92 papers, 1.5k citations indexed

About

I. А. Vаsilyevа is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, I. А. Vаsilyevа has authored 92 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Infectious Diseases, 38 papers in Epidemiology and 28 papers in Surgery. Recurrent topics in I. А. Vаsilyevа's work include Tuberculosis Research and Epidemiology (54 papers), Mycobacterium research and diagnosis (28 papers) and Diagnosis and treatment of tuberculosis (17 papers). I. А. Vаsilyevа is often cited by papers focused on Tuberculosis Research and Epidemiology (54 papers), Mycobacterium research and diagnosis (28 papers) and Diagnosis and treatment of tuberculosis (17 papers). I. А. Vаsilyevа collaborates with scholars based in Russia, United States and United Kingdom. I. А. Vаsilyevа's co-authors include Nyasha Bakare, Rolf P. G. van Heeswijk, Nacer Lounis, Tine De Marez, Paul Meyvisch, Alexander S. Pym, Brian Dannemann, Koen Andries, Martin P. Grobusch and Vaira Leimane and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

I. А. Vаsilyevа

69 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

2014 505 citations I. А. Vаsilyevа et al. profile →

Peers

Countries citing papers authored by I. А. Vаsilyevа

Since Specialization

Citations

This map shows the geographic impact of I. А. Vаsilyevа's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. А. Vаsilyevа with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. А. Vаsilyevа more than expected).

Fields of papers citing papers by I. А. Vаsilyevа

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. А. Vаsilyevа. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. А. Vаsilyevа. The network helps show where I. А. Vаsilyevа may publish in the future.

Co-authorship network of co-authors of I. А. Vаsilyevа

This figure shows the co-authorship network connecting the top 25 collaborators of I. А. Vаsilyevа. A scholar is included among the top collaborators of I. А. Vаsilyevа based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. А. Vаsilyevа. I. А. Vаsilyevа is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Analysis of M. tuberculosis Drug Susceptibility Test Results among Tuberculosis Cases in Russia from 2023 to 2024 2025 ·Tuberculosis and lung diseases ·I. А. Vаsilyevа, (unknown), С. А. Стерликов, (unknown), (unknown), (unknown), Anastasia Samoilova	0
2	Innovative approaches to digital transformation of industrial enterprises 2025 ·(unknown), (unknown), I. А. Vаsilyevа	0
3	Simulation of Conditions and Results of Implementation of Short-Course Treatment Regimes in Tuberculosis Patients 2023 ·SHILAP Revista de lepidopterología ·(unknown), I. А. Vаsilyevа, С. А. Стерликов, (unknown), (unknown), (unknown)	1
4	Chemotherapy for Tuberculosis in Russia – the Story Continues 2023 ·SHILAP Revista de lepidopterología ·I. А. Vаsilyevа, (unknown), (unknown), (unknown), (unknown)	7
5	EKSTRAGENİTAL PATOLOGİYA FONUNDA ANOMAL UŞAQLIQ QANAXMALARI OLAN QADINLARDA ENDOMETRİUMUN ULTRASƏS KEÇİRİCİLİYİNİN XÜSUSİYYƏTLƏRİ 2023 ·(unknown), (unknown), (unknown), (unknown), I. А. Vаsilyevа, (unknown)	1
6	USING TELEMEDICINE TO INCREASE ACCESS TO TREATMENT FOR TUBERCULOSIS PATIENTS 2023 ·International Journal of Infectious Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), I. А. Vаsilyevа	1
7	BUILDING A SEIR-MODEL FOR PREDICTING THE HIV/TUBERCULOSIS COINFECTION EPIDEMIC FOR RUSSIAN TERRITORIES WITH LOW TB BURDEN 2023 ·International Journal of Infectious Diseases ·(unknown), (unknown), Olga Krivorotko, (unknown), (unknown), I. А. Vаsilyevа, (unknown), (unknown)	2
8	VALIDITY OF A NEGATIVE SKIN TEST RESULT WITH RECOMBINANT TUBERCULOSIS ALLERGEN IN ORDER TO EXCLUDE THE ACTIVE TUBERCULOSIS IN CHILDREN 2022 ·PEDIATRIA Journal named after G N SPERANSKY ·(unknown), I. А. Vаsilyevа, (unknown), (unknown), (unknown)	4
9	Tuberculosis situation in children in 2021 and the prospects of its change in 2022 2022 ·SHILAP Revista de lepidopterología ·(unknown), С. А. Стерликов, (unknown), (unknown), (unknown), I. А. Vаsilyevа	3
10	MDR and Pre-XDR Clinical Mycobacterium tuberculosis Beijing Strains: Assessment of Virulence and Host Cytokine Response in Mice Infectious Model 2021 ·Microorganisms ·(unknown), Egor Shitikov, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dmitry Bespiatykh, (unknown), (unknown), (unknown), (unknown), (unknown), Vladimir А. Gushchin, Artem P. Tkachuk, I. А. Vаsilyevа, (unknown), I. A. Dyatlov	6
11	Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), I. А. Vаsilyevа	6
12	Novel coronavirus infection 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), I. А. Vаsilyevа	16
13	HIV RESERVOIR IN HIV PATIENTS 2019 ·Tuberculosis and lung diseases ·(unknown), (unknown), (unknown), I. А. Vаsilyevа	1
14	RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS 2019 ·Tuberculosis and lung diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), I. А. Vаsilyevа	0
15	ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE 2018 ·Tuberculosis and lung diseases ·I. А. Vаsilyevа, (unknown), (unknown), (unknown), (unknown), Л. Н. Черноусова	7
16	ABOUT THE STANDARDIZATION AND QUALITY OF LABORATORY TESTS AIMED AT DIAGNOSTICS AND MONITORING OF TUBERCULOSIS CHEMOTHERAPY 2018 ·Tuberculosis and lung diseases ·(unknown), I. А. Vаsilyevа	0
17	EFFICIENCY OF PULMONARY TUBERCULOSIS CHEMOTHERAPY IN NEW CASES DEPENDING ON THE TIME OFDRUG RESISTANCE DETECTION 2017 ·Tuberculosis and lung diseases ·(unknown), I. А. Vаsilyevа, (unknown), (unknown), (unknown)	6
18	DIAGNOSIS OF TUBERCULOSIS IN HIV-INFECTED PATIENTS 2014 ·SHILAP Revista de lepidopterología ·(unknown), I. А. Vаsilyevа, (unknown), (unknown), (unknown)	2
19	RESULTS OF CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REGIONS OF THE RUSSIAN FEDERATION 2014 ·SHILAP Revista de lepidopterología ·(unknown), С. А. Стерликов, I. А. Vаsilyevа, Victor Erokhin, (unknown)	1
20	SPECIFIC FEATURES OF PSYCHOLOGICAL CARE FOR PATIENTS WITH PULMONARY TUBERCULOSIS DURING INTENSIVE CHEMOTHERAPY (IN THE HOSPITAL SETTING) 2014 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), I. А. Vаsilyevа	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact